BIOMAT Database Logo BIOMAT Database Logo

[Our previous experiences with thio-TEPA in therapy and prevention of bladder papilloma]. 1967

E Zingg, and G Rutishauser

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013852 Thiotepa A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). Thio-Tepa,Thiophosphamide,Triethylenethiophosphoramide,AI3-24916,Girostan,NSC-6396,Tespa,Tespamin,Tris(1-aziridinyl)phosphine Sulfide,AI3 24916,AI324916,NSC 6396,NSC6396,Thio Tepa

Related Publications

E Zingg, and G Rutishauser
[Adjuvant thio-tepa in the treatment of bladder papilloma. A prospective randomized study].
June 1980, Ugeskrift for laeger,
E Zingg, and G Rutishauser
[Thio-tepa in the treatment of vesical papilloma].
January 1971, Journal d'urologie et de nephrologie,
E Zingg, and G Rutishauser
[Thio-tepa in the prevention of recurrences of papillary bladder tumors].
August 1973, Zeitschrift fur Urologie und Nephrologie,
E Zingg, and G Rutishauser
[Thio-tepa treatment for prevention of recurrence of surgically treated bladder tumors].
January 1980, Revista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie,
E Zingg, and G Rutishauser
[Dibunol and thio-TEPA treatment of bladder tumors].
January 1978, Urologiia i nefrologiia,
E Zingg, and G Rutishauser
[Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
June 1977, Polski przeglad chirurgiczny,
E Zingg, and G Rutishauser
[Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
June 1977, Minerva medica,
E Zingg, and G Rutishauser
[Agranulocytic reaction associated with thio-tepa therapy].
May 1971, Klinicheskaia meditsina,
E Zingg, and G Rutishauser
Prevention of experimental lung metastases with triethylenethiophosphoramide (thio TEPA).
April 1958, Surgery, gynecology & obstetrics,
E Zingg, and G Rutishauser
Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
January 1979, International urology and nephrology,
Copied contents to your clipboard!